Based on the research and analysis of the Chinese disposable electronic hysteroscopy integrated diagnosis and treatment equipment market in recent years, as well as the research and evaluation of related companies in the industry, the globally renowned growth consulting firm Frost & Sullivan (Frost & Sullivan, abbreviated as: Frost & Sullivan) awarded 'Innovation Award for Disposable Electronic Hysteroscopy Integrated Diagnosis and Treatment Equipment in China' to Shanghai Yudu Medical Technology Co., Ltd. (hereinafter referred to as 'Yudu Medicine'). The award was presented by Mr. Wang Chenhui, Managing Partner and Executive Vice President of Frost & Sullivan Greater China, to Mr. Wang Chenfeng, Vice President of Shanghai Yudu Medical Technology Co., Ltd.
Frost & Sullivan has awarded Shanghai Yudu Medical Technology Co., Ltd.
"China One-Time-use Electronic Hysteroscopy Integrated Diagnosis and Treatment Equipment Innovation Award"


Mr. Wang Chenhui presented the award to Mr. Wang Chenfeng, Vice President of Yudu Medicine
Leading in minimally invasive gynecological diagnosis and treatment, Yudu Medical is committed to creating globally leading medical technologies and products for customers.
Yudu Medical was founded in 2006. The company focuses on technology and product research and development in the fields of high-end endoscopes, medical ultra-high-definition imaging systems, medical special light imaging, gynecological flow cytometry big data software, gynecological pathology, and AI-assisted diagnosis and treatment in imaging. It has established long-term strategic cooperative relationships with domestic and international universities and research institutions, continuously increasing investment in R&D expenses and the introduction of R&D talents, and possesses a complete national sales network and channels.
"Immediate diagnosis and treatment", Yudu Medical Innovation provides disposable electronic hysteroscopy.
Yudu Medical has targeted issues such as the long preparation time, difficulty in entering the uterine cavity, complex procedures, and risk of cross-infection with traditional hysteroscopic instruments. It has successfully developed a DOHIS disposable hysteroscopic overall solution. It features multiple innovations such as non-planar continuous convection, dual-pump constant-pressure uterine distension, intraoperative safe electrocoagulation, automatic biopsy under the microscope, segmented rapid tandem operation, intraoperative instrument shaping, rapid wall-penetrating surgery, and high-definition wide-angle surgical field. While inheriting the high-definition resolution of optical microscopes (the world's first disposable high-definition hysteroscope) and the ability for immediate diagnosis and treatment, it has achieved original technological breakthroughs such as simplified and efficient operations, rapid tissue sampling under the microscope, continuous maintenance of a high-definition surgical field, comprehensive management of hysteroscopic complications, and a significant increase in the success rate of non-anesthetic surgeries. It provides an innovative overall solution of 'immediate diagnosis and treatment'.
With a wide range of indications, the DOHIS disposable electronic hysteroscope provides innovative solutions.
The Yudu Medical DOHIS disposable electronic hysteroscope product can be applied in multiple clinical scenarios such as abnormal uterine bleeding, endometrial evaluation and diagnosis and treatment of intrauterine diseases, cancer screening for endometrial cancer lesions, and post-abortion endometrial evaluation. It has a broad range of indications. Compared with traditional hysteroscopy, the DOHIS disposable electronic hysteroscope has more advantages in terms of cost, efficiency, and prevention of nosocomial infections: only one integrated device needs to be purchased, resulting in low procurement and operating costs; it saves time, reducing the time cost by 6 times compared to traditional equipment, and can meet the needs of a large number of outpatient patients; it is sterile packaged and disposable, reducing the risk of nosocomial cross-infection.
About the Frost & Sullivan Life Sciences New Investment Summit
The 2023 Frost & Sullivan Life Sciences New Investment Summit Forum was held on September 27-28, with the theme of 'New Directions for the Future: Forging Ahead'. It brought together more than 30 industry leaders, life science companies, investment institutions, and professional service providers to focus on new investment opportunities in life sciences and explore the capital and industrial forces that enable enterprises to navigate cycles.
About the Frost & Sullivan China Innovation Award
The Frost & Sullivan China Innovation Award recognizes outstanding performance and achievements in technological innovation, market potential, customer service, brand, and other aspects by enterprises. The Frost & Sullivan team nominates a competitive group of excellent companies to the independent judging panel through methods such as in-depth interviews, industry analysis, and secondary research. The independent judging panel, composed of third-party investment and financing experts, financial experts, bankers, and renowned listed entrepreneurs, conducts a rigorous review of the companies nominated by the Frost & Sullivan team and decides to award the 'China One-Time Electronic Hysteroscopy Integrated Diagnosis and Treatment Equipment Innovation Award' to Shanghai Yudu Medical Technology Co., Ltd.


